Discover how precision lung cancer care tackles gene fusions, new HER2/ROS1/ALK drugs, expanded screening, and liquid biopsies shaping 2026 treatment.
Bruna Pellini, MD
Bruna Pellini, MD, is the chief of Thoracic Medical Oncology at Baptist Health Miami Cancer Institute.
Articles by Bruna Pellini, MD
New targeted drugs transform HER2, ROS1 and ALK lung cancer care, boosting brain response and survival—while precision choices still matter.
South Florida’s diverse lung cancer cases fuel genomic breakthroughs, push screening beyond smokers, and accelerate 2026 targeted-therapy progress.
Latest Updated Articles
Dr Pellini on Lung Cancer Disparities and InnovationFebruary 10th 2026